Skip to main content

Table 1 Results of immunohistochemistry

From: The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer

Variables

E-cadherin

Snail (nuclear)

 

Preserved (%)

Reduced (%)

p-value

Negative (%)

Positive (%)

p-value

Age

  

0.80

  

0.14

  < 50

29 (61.7)

18 (38.3)

 

27 (57.4)

20 (42.6)

 

  ≥ 50

81 (63.8)

46 (36.2)

 

88 (69.3)

39 (30.7)

 

Histology

  

<0.01

  

<0.05

  Serous

30 (62.5)

18 (37.5)

 

34 (70.8)

14 (29.2)

 

  Mucinous

17 (81.0)

4 (19.0)

 

7 (33.3)

14 (66.7)

 

  Clear

16 (50.0)

16 (50.0)

 

23 (71.9)

9 (28.1)

 

  Endometrioid

27 (84.4)

5 (15.6)

 

22 (68.8)

10 (31.2)

 

  SSPC

13 (50.0)

13 (50.0)

 

17 (65.4)

9 (34.6)

 

  Others

7 (46.7)

8 (53.3)

 

12 (80.0)

3 (20.0)

 

FIGO stage

  

0.39

  

0.68

  I

39 (69.6)

17 (30.4)

 

40 (71.4)

16 (28.6)

 

  II

9 (64.3)

5 (35.7)

 

10 (71.4)

4 (28.6)

 

  III

53 (62.3)

32 (37.7)

 

53 (62.3)

32 (37.7)

 

  IV

9 (47.3)

10 (52.7)

 

12 (63.2)

7 (36.8)

 

Peritoneal cytology

  

0.91

  

0.18

  Positive

85 (63.4)

49 (36.6)

 

85 (63.4)

49(36.6)

 

  Negative

25 (62.5)

15 (37.5)

 

30 (75.0)

10 (25.0)

 

Lymph node metastasis

  

0.25

  

0.14

  Positive

22 (66.7)

11 (33.3)

 

19 (57.6)

14 (42.4)

 

  Negative

60 (67.4)

29 (32.6)

 

65 (73.0)

24 (27.0)

 

  Nx*

28 (53.8)

24 (46.2)

 

31 (59.6)

21 (40.4)

 

Peritoneal dissemination

  

0.09

  

0.10

  Positive

54 (57.4)

40 (42.6)

 

57 (60.6)

37 (39.4)

 

  Negative

56 (70.0)

24 (30.0)

 

58 (72.5)

22 (27.5)

 

Recurrence

  

<0.01

  

0.73

  −

30 (44.1)

38 (55.9)

 

46 (67.6)

22 (32.4)

 

  +

80 (75.5)

26 (24.5)

 

69 (65.1)

37 (34.9)

 

End stage

  

<0.05

  

0.09

  Alive

79 (68.7)

36 (31.3)

 

81 (70.4)

34 (29.6)

 

  Dead

31 (52.5)

28 (47.5)

 

34 (57.6)

25 (42.4)

 
  1. *Nx: no lymphadenectomy.